Table 1 Study outcomes
Outcome measures in infants with birth weight below 10 th percentile and their mothers | PRIMARY |
- Neonatal mortality at 28 days | |
SECONDARY | |
- Rate of antenatal corticosteroid use | |
- Maternal infection from birth up to 7 and 42 days postpartum | |
- Perinatal mortality rate (stillbirths ≥ 20 weeks GA or ≥ 500 g + neonatal deaths before 7 days) | |
- Early neonatal mortality rate at 7 days after birth | |
- Mean neonatal weight at 7 and 28 days | |
- Neonatal and perinatal mortality rates by country | |
- Neonatal and perinatal mortality rates by type of setting (health facility based deliveries vs. community based deliveries) | |
- Infant mortality rate at 42 days after birth. | |
Outcome measures in all infants and their mothers | - Early neonatal mortality (7 days after birth) |
- Neonatal mortality at 28 days after birth | |
- Maternal infection from birth up to 7 days postpartum | |
- Maternal infection from birth up to 42 days postpartum | |
- Infant mortality rate at 42 days after birth | |
Process measures | - Number of women receiving corticosteroids and number of doses |
- Number of referrals | |
- Number of health providers trained | |
- Number of kits distributed | |
- Health providers’ opinions about the kits | |
- Number of kits fully used (all doses administered) at site | |
- Number of kits partially used (1–3 doses of dexamethasone) at site |